PHILADELPHIA, Pennsylvania, Oct. 23 -- Cancer Epidemiology, Biomarkers and Prevention, a peer-reviewed journal from the American Association for Cancer Research that says it publishes population-based research on cancer etiology, prevention, surveillance and survivorship, published research articles on the following topics in its October 2023 edition (Vol. 32, Issue 10): Research Articles: * Identifying Neighborhoods with Cervical Cancer Disparities for Targeted Community Outreach and Engageme  more

WASHINGTON, Oct. 20 -- The U.S. Department of Homeland Security's Immigration and Customs Enforcement issued the following news release: BOSTON -- Enforcement and Removal Operations (ERO) Boston arrested an unlawfully present Brazilian national who, since July 21, has been wanted in Brazil by law enforcement authorities for aggravated homicide of a child under the age of 14. ERO Boston officers arrested the 52-year-old Brazilian national on federal immigration violations near his residence in P  more

WASHINGTON, Oct. 18 -- The Federal Trade Commission issued the following remarks by Chairwoman Lina M. Khan at the International Competition Network conference: * * * Over the last decade, we've heard mounting concerns about inadequate competition across key markets in the U.S. economy. Evidence suggests that decades of mergers have been a key driver of weakened competition and economic dynamism. As President Biden noted in his Executive Order on Promoting Competition, industry consolidation h  more

HOUSTON, Texas, Oct. 23 (TNSres) -- The University of Texas's MD Anderson Cancer Center issued the following news release: * * * MD Anderson-led study shows benefits over chemotherapy for patients previously treated with immunotherapy * * * Targeted treatment with the fibroblast growth factor receptor (FGFR) inhibitor erdafitinib improved responses and overall survival compared to standard chemotherapy for patients with metastatic urothelial cancers with FGFR alterations. Results from the Ph  more